Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Laboratory Services

 

PMI resilient through Brazil’s recession

Unemployment may have crashed from 4% to 10.9% in the first quarter of 2016, but the number of lives covered by private medical insurance has fallen just 3.1% in 15 months. That is despite a 3.8% drop in GDP in 2015 and forecasts of a similar fall in 2016.

Lancet shows the way in African labs

Dr. Peter Clarke from South African lab group Lancet laid out his pan-African expertise at our 2016 Breaking Barriers conference. What business models work in Kenya? What about Nigeria, to the other side of the continent? Most private equity houses and institutional investors are daunted by Africa, but Lancet has expanded to 11 countries in just 12 years.

Thyrocare IPO subscribed 73 times over

Indian healthcare equities are still highly prized if the INR 480 crore (US$72m) IPO of the lab group, Thyrocare, is to be believed. The available shares were oversubscribed 73 times.

Labs still depend on staff

Surprisingly, some 73% of activities within labs are still manual, suggesting technological innovations have failed to revolutionise the industry. Chris Fourie, a partner at LTS Consulting, says much technical innovation is not financially viable given the size of many labs. Equipment is also getting larger and swamping labs with limited ground space such as hospital hot labs.

SRL plans African strategy

Indian lab group SRL is close to deal in Nigeria for a second Africa lab hub and a third is planned for Kenya. Its Congo lab already serves seven countries, CEO Sanjeev Vashishta told Healthcare Nova at the Healthcare Business International 2016 conference.

“Fast and furious growth” – A survey of private healthcare operators in Europe and Emerging Markets

Big for-profit healthcare operators expect to grow sales at over 10% annually for the next five years in Developed and Emerging Markets, but what do they see as their main challenges? A fascinating picture is revealed in a new survey of 81 mainly CEOs and CXOs in 37 countries of predominately large hospital chains, diagnostic lab and imaging players, commissioned by Siemens Healthineers (the new name for Siemens Healthcare) from Healthcare Business International. The quantitive survey was followed up with depth interviews with a dozen respondents.

“Fast and furious growth” – A survey of private healthcare operators in Europe and Emerging Markets

Big for-profit healthcare operators expect to grow sales at over 10% annually for the next five years in Developed and Emerging Markets, but what do they see as their main challenges? A fascinating picture is revealed in a new survey of 81 mainly CEOs and CXOs in 37 countries of predominately large hospital chains, diagnostic labs and imaging players, commissioned by Siemens Healthineers (the new name for Siemens Healthcare) from Healthcare Business International. The quantitive survey was followed up with depth interviews with a dozen respondents.

Regulators will cut test volumes

Up to 85% of lab tests will be void within ten years predicts Dr Charles Woler, CEO of Eurofins Biologie Spécilisée. Woler said that regulators are looking to cut tests through incentives and also by reducing the range of reimbursed tests.

Saudi’s five-year PPP plan

Plans to implement mandatory health insurance and expand capacity with new PPP contracts were laid out by Dr. Ibrahim Al-Omar, former Deputy Minister at the Saudi Ministry of Health, at our 2016 Breaking Barriers conference.

Find Us